Immunosuppressive drugs modes of action
- PMID: 34874841
- DOI: 10.1016/j.bpg.2021.101757
Immunosuppressive drugs modes of action
Abstract
The innate and adaptive immune systems work as a complex interplay between different cell types, involving cytokines and chemokines mediating extracellular and paracrine effects. At the intracellular level, the inflammatory cascade is mediated by multifaceted processes that have been better described in the last 10 years. Immunosuppressive agents available in clinical practice act at different points of those cascades at the intracellular or extracellular level. Those drugs can mediate their effects on one or more cell types finally limiting inflammation and immune responses to antigens. Every immunosuppressive agent is characterized by intrinsic toxicity and side effects that may be due to the same therapeutic pathways or to off-target secondary effect of each molecule. We will here review the mechanisms of action of the most widely used immunosuppressive agents in the field of solid organ transplantation and autoimmune disorders, describing the mechanisms underlying both the therapeutic and secondary effects.
Keywords: Allotransplantation; Autoimmunity; Immunosuppression.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.
Similar articles
-
[Immunosuppressive drugs--useful confusion of the 20th century?].Ther Umsch. 1999 Dec;56(12):708-12. doi: 10.1024/0040-5930.56.12.708. Ther Umsch. 1999. PMID: 10638277 Review. German.
-
Genetics of drug response to immunosuppressive treatment and prospects for personalized therapy.Mol Med Today. 2000 Dec;6(12):475-82. doi: 10.1016/s1357-4310(00)01822-0. Mol Med Today. 2000. PMID: 11099953 Review.
-
Immune monitoring to predict the development of infections after immunosuppression for solid organ transplantation and autoimmune diseases.Curr Drug Saf. 2008 May;3(2):91-9. doi: 10.2174/157488608784529260. Curr Drug Saf. 2008. PMID: 18690987 Review.
-
Immunological risk factors for infection after immunosuppressive and biologic therapies.Expert Rev Anti Infect Ther. 2011 Apr;9(4):405-13. doi: 10.1586/eri.10.178. Expert Rev Anti Infect Ther. 2011. PMID: 21504398 Review.
-
The Effect of Immunosuppressive Drugs on MDSCs in Transplantation.J Immunol Res. 2018 Jul 3;2018:5414808. doi: 10.1155/2018/5414808. eCollection 2018. J Immunol Res. 2018. PMID: 30057917 Free PMC article. Review.
Cited by
-
Influence of single-nucleotide polymorphisms in TLR3 (rs3775291) and TLR9 (rs352139) on the risk of CMV infection in kidney transplant recipients.Front Immunol. 2022 Jul 29;13:929995. doi: 10.3389/fimmu.2022.929995. eCollection 2022. Front Immunol. 2022. PMID: 35967300 Free PMC article.
-
[Anesthesia for organ transplant patients].Anaesthesiologie. 2023 Nov;72(11):773-783. doi: 10.1007/s00101-023-01332-x. Epub 2023 Oct 24. Anaesthesiologie. 2023. PMID: 37874343 Free PMC article. Review. German.
-
Interplay between Liposomes and IgM: Principles, Challenges, and Opportunities.Adv Sci (Weinh). 2023 Jul;10(20):e2301777. doi: 10.1002/advs.202301777. Epub 2023 May 7. Adv Sci (Weinh). 2023. PMID: 37150860 Free PMC article. Review.
-
Evaluation of THP-1 and Jurkat Cell Lines Coculture for the In Vitro Assessment of the Effects of Immunosuppressive Substances.Toxics. 2024 Aug 19;12(8):607. doi: 10.3390/toxics12080607. Toxics. 2024. PMID: 39195709 Free PMC article.
-
Distinct autoantibody profiles across checkpoint inhibitor types and toxicities.Oncoimmunology. 2024 May 9;13(1):2351255. doi: 10.1080/2162402X.2024.2351255. eCollection 2024. Oncoimmunology. 2024. PMID: 38737792 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
